| Product Code: ETC7753043 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Angiogenesis Inhibitors Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Angiogenesis Inhibitors Market Revenues & Volume, 2021 & 2031F |
3.3 Jordan Angiogenesis Inhibitors Market - Industry Life Cycle |
3.4 Jordan Angiogenesis Inhibitors Market - Porter's Five Forces |
3.5 Jordan Angiogenesis Inhibitors Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Jordan Angiogenesis Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Jordan Angiogenesis Inhibitors Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Jordan Angiogenesis Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Jordan Angiogenesis Inhibitors Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Jordan Angiogenesis Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Jordan Angiogenesis Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and other angiogenesis-related diseases in Jordan |
4.2.2 Growing awareness about the benefits of angiogenesis inhibitors in cancer treatment |
4.2.3 Technological advancements leading to the development of more effective angiogenesis inhibitors |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Jordan |
4.3.2 High cost associated with angiogenesis inhibitors which may limit affordability for some patients |
5 Jordan Angiogenesis Inhibitors Market Trends |
6 Jordan Angiogenesis Inhibitors Market, By Types |
6.1 Jordan Angiogenesis Inhibitors Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By VEGF Targeted Therapy, 2021- 2031F |
6.1.4 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By FGF Targeted Therapies, 2021- 2031F |
6.1.5 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By Oncogene Targeted Therapy, 2021- 2031F |
6.1.6 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By Matrix Degrading and Remodeling Targeted Therapy, 2021- 2031F |
6.1.7 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Jordan Angiogenesis Inhibitors Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By Glioblastoma, 2021- 2031F |
6.2.3 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.4 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Jordan Angiogenesis Inhibitors Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By Inlyta, 2021- 2031F |
6.3.3 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By Avastin, 2021- 2031F |
6.3.4 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By Revlimid, 2021- 2031F |
6.3.5 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Jordan Angiogenesis Inhibitors Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Jordan Angiogenesis Inhibitors Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Jordan Angiogenesis Inhibitors Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Jordan Angiogenesis Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
7 Jordan Angiogenesis Inhibitors Market Import-Export Trade Statistics |
7.1 Jordan Angiogenesis Inhibitors Market Export to Major Countries |
7.2 Jordan Angiogenesis Inhibitors Market Imports from Major Countries |
8 Jordan Angiogenesis Inhibitors Market Key Performance Indicators |
8.1 Number of clinical trials conducted for angiogenesis inhibitors in Jordan |
8.2 Adoption rate of angiogenesis inhibitors in cancer treatment |
8.3 Research and development investment in new angiogenesis inhibitors technologies |
9 Jordan Angiogenesis Inhibitors Market - Opportunity Assessment |
9.1 Jordan Angiogenesis Inhibitors Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Jordan Angiogenesis Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Jordan Angiogenesis Inhibitors Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 Jordan Angiogenesis Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Jordan Angiogenesis Inhibitors Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Jordan Angiogenesis Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Jordan Angiogenesis Inhibitors Market - Competitive Landscape |
10.1 Jordan Angiogenesis Inhibitors Market Revenue Share, By Companies, 2024 |
10.2 Jordan Angiogenesis Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here